{"product_id":"ret4trutid3-40mg","title":"Ret4trutid3 40Mg","description":"\u003cp\u003e\u003cmeta charset=\"utf-8\"\u003e\u003c\/p\u003e\n\u003ch1\u003e\u003cspan\u003eRETATRUTIDE — Investigational Triple Receptor Agonist for Metabolic Research\u003c\/span\u003e\u003c\/h1\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eAdvanced Metabolic Research | GLP-1, GIP \u0026amp; Glucagon Receptor Agonist | Obesity \u0026amp; Type 2 Diabetes Investigation\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eProduct Overview\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eRetatrutide is an innovative, first-in-class investigational peptide developed by Eli Lilly, designed to simultaneously activate three key metabolic hormone receptors: GLP-1, GIP, and glucagon.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThis triple receptor agonist is being investigated for its potential applications in obesity management, type 2 diabetes, and metabolic disorders.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eBy targeting multiple pathways involved in appetite regulation, glucose metabolism, energy expenditure, and metabolic homeostasis, retatrutide represents an emerging approach to metabolic pharmacology.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eMechanism of Action\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eRetatrutide combines three complementary hormonal mechanisms within a single molecule.\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eGLP-1 Receptor Activation:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Influences appetite regulation, promotes satiety, and supports glucose-dependent insulin secretion.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eGIP Receptor Activation:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Participates in glucose-dependent insulin regulation and metabolic signaling.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eGlucagon Receptor Activation:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Influences hepatic energy metabolism and may contribute to increased energy expenditure.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eIntegrated Metabolic Regulation:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Simultaneous activation of these pathways is being investigated for its combined effects on body weight, glycemic control, and energy homeostasis.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cspan\u003eClinical Research \u0026amp; Findings\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eRetatrutide has demonstrated substantial weight reduction in clinical trials, including advanced Phase III studies.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eReported findings include:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eUp to 24.2% mean body weight reduction after 48 weeks\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e in a Phase II trial involving participants receiving the highest studied dose.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003e28.3% average weight reduction over 80 weeks\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e in the Phase III TRIUMPH-1 study among participants receiving the 12 mg investigational dose.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eImproved glycemic control\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e in studies involving adults with type 2 diabetes.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eContinued investigation of cardiometabolic outcomes\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e, including obesity-related complications and metabolic health.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eThese results were obtained under controlled clinical trial conditions and should not be interpreted as guaranteed outcomes.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003ePotential Research Applications\u003c\/span\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eObesity Research:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Investigation of hormonal pathways involved in body weight regulation.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eType 2 Diabetes Research:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Evaluation of glucose metabolism, insulin response, and glycemic control.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eEnergy Homeostasis:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Exploration of interactions between appetite, energy intake, and energy expenditure.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eMetabolic Pharmacology:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Research into the combined biological effects of GLP-1, GIP, and glucagon receptor activation.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eCardiometabolic Research:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Investigation of obesity-associated metabolic complications.\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003eThese represent active areas of clinical investigation rather than approved therapeutic indications.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eClinical Development \u0026amp; Safety\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eAs of November 2026, \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eretatrutide remains an investigational pharmaceutical candidate undergoing advanced clinical development and has not received regulatory approval for general clinical use.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eCommonly reported adverse events in clinical trials have included gastrointestinal symptoms such as nausea, vomiting, and diarrhea. Its complete long-term safety profile remains under evaluation.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eAlthough clinical findings are promising, retatrutide's clinical use requires appropriate regulatory authorization and further assessment of its benefits and risks.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eResearch Use Only\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eFOR AUTHORIZED SCIENTIFIC AND CLINICAL RESEARCH PURPOSES ONLY.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eIntended exclusively for qualified professionals conducting legitimate scientific investigations and appropriately authorized clinical research.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eNot approved for general human or veterinary use. Not intended for personal injection, self-administration, or unsupervised therapeutic applications.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eNot intended for routine diagnosis, treatment, cure, or prevention of disease outside authorized clinical research.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eThe designation “Research Use Only” does not constitute authorization to manufacture, distribute, or administer an investigational medicine.\u003c\/span\u003e\u003c\/p\u003e\n\u003cdiv\u003e\u003chr\u003e\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003ePEPTITAN — PRECISION. SCIENCE. RESEARCH.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":59501947552008,"sku":null,"price":500.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1078\/2942\/8488\/files\/Frasco_de_Vidro_com_Arcos_Dourados.png?v=1794657660","url":"https:\/\/peptgrind.com\/products\/ret4trutid3-40mg","provider":"peptitan","version":"1.0","type":"link"}